Medtronic recalls MiniMed 740G insulin pumps (MMT-1811-1862) due to potential insulin over- or under-delivery when pump height changes, risking severe hypoglycemia or hyperglycemia. Affected users should contact Medtronic for guidance.
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Medtronic is recalling MiniMed 740G insulin pumps with specific model numbers because they can deliver too much or too little insulin if the pump is moved up or down relative to the body. This could cause life-threatening low blood sugar or high blood sugar conditions.
When the pump is elevated above the infusion site, it can deliver too much insulin, causing severe hypoglycemia that may lead to seizures, coma, or death. When the pump is lowered below the infusion site, it can deliver too little insulin, causing severe hyperglycemia that may lead to dehydration or diabetic ketoacidosis.
People using the MiniMed 740G insulin pump (model numbers MMT-1811 through MMT-1862) are affected. Those with diabetes who rely on this pump for insulin delivery are most at risk.
Check for the model numbers MMT-1811, MMT-1812, MMT-1861, or MMT-1862 on the pump's label. These pumps were sold with specific serial numbers listed in the recall notice.
Look for the model numbers MMT-1811, MMT-1812, MMT-1861, or MMT-1862 on the pump's label to confirm if it's affected.
Reach out to Medtronic directly for specific guidance on how to proceed with the recall.
The affected models are MMT-1811, MMT-1812, MMT-1861, and MMT-1862.
Yes, insulin over-delivery can cause severe hypoglycemia leading to seizures, coma, or death. Under-delivery can cause severe hyperglycemia leading to dehydration or diabetic ketoacidosis.
Check the pump model number and contact Medtronic for specific instructions on how to proceed with the recall.
We’ve drafted a message you can send Medtronic to request your refund or repair — edit it as you like.
Subject: Recall Z-1746-2026 — Medtronic Medtronic Hello, I own a Medtronic that is covered by recall Z-1746-2026 from Medtronic. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
